Deep-pocketed traders have adopted a bearish method in the direction of Viking Therapeutics VKTX, and it is one thing market gamers should not ignore. Our monitoring of public choices data at Benzinga unveiled this important transfer right now. The id of those traders stays unknown, however such a considerable transfer in VKTX often suggests one thing massive is about to occur.
We gleaned this data from our observations right now when Benzinga’s choices scanner highlighted 9 extraordinary choices actions for Viking Therapeutics. This stage of exercise is out of the peculiar.
The overall temper amongst these heavyweight traders is split, with 0% leaning bullish and 77% bearish. Amongst these notable choices, 4 are places, totaling $180,170, and 5 are calls, amounting to $377,168.
What’s The Worth Goal?
After evaluating the buying and selling volumes and Open Curiosity, it is evident that the main market movers are specializing in a worth band between $20.0 and $75.0 for Viking Therapeutics, spanning the final three months.
Quantity & Open Curiosity Growth
By way of liquidity and curiosity, the imply open curiosity for Viking Therapeutics choices trades right now is 486.33 with a complete quantity of 113.00.
Within the following chart, we’re capable of observe the event of quantity and open curiosity of name and put choices for Viking Therapeutics’s massive cash trades inside a strike worth vary of $20.0 to $75.0 over the past 30 days.
Viking Therapeutics Name and Put Quantity: 30-Day Overview
Vital Choices Trades Detected:
| Image | PUT/CALL | Commerce Sort | Sentiment | Exp. Date | Ask | Bid | Worth | Strike Worth | Whole Commerce Worth | Open Curiosity | Quantity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $33.3 | $34.73 | $20.00 | $173.6K | 299 | 24 |
| VKTX | CALL | TRADE | NEUTRAL | 01/16/26 | $33.8 | $29.1 | $31.48 | $25.00 | $94.4K | 54 | 30 |
| VKTX | PUT | TRADE | BEARISH | 09/20/24 | $9.1 | $8.6 | $8.91 | $50.00 | $62.3K | 954 | 2 |
| VKTX | PUT | SWEEP | BEARISH | 11/15/24 | $6.0 | $5.9 | $6.0 | $40.00 | $53.4K | 915 | 40 |
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $37.0 | $35.5 | $35.75 | $20.00 | $39.3K | 299 | 2 |
About Viking Therapeutics
Viking Therapeutics Inc is a healthcare service supplier. The corporate specializes within the space of biopharmaceutical improvement targeted on metabolic and endocrine issues. The corporate’s scientific program pipeline consists of VK2809, VK5211, VK0214 merchandise. VK2809 and VK0214 are orally out there, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally out there, non-steroidal selective androgen receptor modulator.
Having examined the choices buying and selling patterns of Viking Therapeutics, our consideration now turns on to the corporate. This shift permits us to delve into its current market place and efficiency
Viking Therapeutics’s Present Market Standing
- With a buying and selling quantity of 1,554,339, the worth of VKTX is down by -0.42%, reaching $49.63.
- Present RSI values point out that the inventory is is presently impartial between overbought and oversold.
- Subsequent earnings report is scheduled for six days from now.
Professional Opinions on Viking Therapeutics
Over the previous month, 2 trade analysts have shared their insights on this inventory, proposing a mean goal worth of $97.5.
- In a cautious transfer, an analyst from Morgan Stanley downgraded its score to Chubby, setting a worth goal of $105.
- An analyst from HC Wainwright & Co. downgraded its motion to Purchase with a worth goal of $90.
Buying and selling choices entails larger dangers but in addition presents the potential for greater income. Savvy merchants mitigate these dangers by ongoing schooling, strategic commerce changes, using numerous indicators, and staying attuned to market dynamics. Sustain with the most recent choices trades for Viking Therapeutics with Benzinga Professional for real-time alerts.
